🇺🇸 FDA
Patent

US 6613883

Screening assays for compounds that cause apoptosis and related compounds

expired A61KA61K38/1709

Quick answer

US patent 6613883 (Screening assays for compounds that cause apoptosis and related compounds) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Sep 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/1709